[Clinical and neurophysiological findings in serum controlled diphenylhydantoin application - considerations on myotonic dystrophy therapy].
A report is given on the possible therapeutic influence of diphenylhydantoin on dystrophic myotonia. After studying the correlations of the clinical-neurological findings, EEG changes and electromyo-electroneurographic findings with respect to the DPH serum concentration, it was found that a long-term therapy is only indicated in individual cases and when the patient is taken thorough care of.
D000293:Adolescent; D000328:Adult; D004569:Electroencephalography; D004576:Electromyography; D006801:Humans; D008297:Male; D008875:Middle Aged; D009136:Muscular Dystrophies / Q000097:blood / Q000188:drug therapy*; D010672:Phenytoin / Q000097:blood* / Q000627:therapeutic use
D010672:Phenytoin
Klinische und neurophysiologische Befunde bei blutspiegelkontrollierter Diphenylhydantoinapplikation - Uberlegung zur Therapie der myotonen Dystrophie.